Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 69   

Articles published

GSK 1,490.00 -10.00 (-0.67%)
price chart
Hikma Beats GSK, Pfizer In Argatroban IP Infringement Row
Law360, New York (July 31, 2012, 7:17 PM ET) -- GlaxoSmithKline PLC and Pfizer Inc. on Tuesday failed to stop Hikma Pharmaceutical Co.
GlaxoSmithKline fined $3bn after bribing doctors to increase drugs sales
The pharmaceutical group GlaxoSmithKline has been fined $3bn (�1.9bn) after admitting bribing doctors and encouraging the prescription of unsuitable antidepressants to children.
Glaxo in $3 Billion Settlement
Drug maker GlaxoSmithKline PLC agreed to plead guilty to criminal charges of illegally marketing drugs and withholding safety data from U.S.
Glaxo Pleads Guilty, Fined $1 Billion in Drug-Marketing Case  Businessweek
Record fine for UK drug company over fraud  FRANCE 24
Related articles »  
Stocks That Avoid Unrecoverable Foreign Dividend Withholding In Tax Deferred ...
While we cannot be entirely certain, it appears that BHP (the Australian ADR for BHP Billiton plc) is partially franked. However, since the other BHP Billiton plc ADR (BBL) is U.K. based, paying a higher net yield (not subject to dividend tax ...
SEC filing: GlaxoSmithKline makes clean sweep of Human Genome Sciences ...
GlaxoSmithKline PLC has removed all of the executive officers of Human Genome Sciences Inc. as part of its $3.6 billion acquisition of the Rockville-based biotech, including President and CEO Tom Watkins, according to a securities filing on Monday.
Related articles »  
Big Pharma is in big trouble � or should be
Something is definitely wrong in their management and monitoring systems. GSK are not able to say that the activities for which they were fined were anything other than deliberate.
Related articles »  
GlaxoSmithKline to acquire Human Genome Sciences
After spurning a hostile takeover bid from GlaxoSmithKline PLC in April, Human Genome Sciences Inc. said Monday it agreed to be bought by the biopharmaceutical giant for a more lucrative offer valued at $3.6 billion.
Glaxo to Buy Human Genome  Wall Street Journal
GSK clinches $3B deal to buy Human Genome  National Post
Related articles »  
GlaxoSmithKline Agrees To Plead Guilty, Pay $3B Settlement
Drug maker GlaxoSmithKline PLC agreed to plead guilty to criminal charges of illegally marketing drugs and withholding safety data from U.S.
GlaxoSmithKline pays US$3-billion to settle biggest healthcare fraud case in ...  Financial Post (blog)
GlaxoSmithKline to pay $3B in healthcare fraud  Emirates 24/7
Related articles »  
3 U.K. Stocks With U.S.-Style Dividends And No Tax Withholding For A Dividend ...
GlaxoSmithKline PLC - This is one of the largest pharmaceutical companies in the world, having a market capitalization of $116 billion.
Glaxo Tries to Shake Marketing Questions on Advair
According to the U.S. government, from 2001 through "at least 2010," Glaxo used illegal marketing tactics to promote Advair, an inhaler licensed to treat moderate to severe forms of asthma.
Related articles »